Peptide companies in the United States have witnessed unprecedented growth, with the FDA approving a record number Eli Lilly supplier of peptide-based therapeutics in recent years. Indeed, these specialized molecules now account for over 5% of all approved drugs, underscoring their growing importance in modern medicine. The complex nature of peptid